Sunshine Biopharma Inc.
Symbol: SBFM (NASDAQ)
1.49
▼ (-2.30%) -0.035
Company Description:
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Key Stats
- Today's Open: $1.49
- Today's High: $1.53
- Today's Low: $1.47
- Today's Volume: 94.01K
- Yesterday Close: $1.52
- Yesterday High: $1.6
- Yesterday Low: $1.46
- Yesterday Volume: 72.88K
- Last Min Volume: 15
- Last Min High: $1.485
- Last Min Low: $1.485
- Last Min VWAP: $1.485
Company Profile
- Name: Sunshine Biopharma Inc.
- Website: https://www.sunshinebiopharma.com
- Listed Date: 2007-08-09
- Location: FORT LAUDERDALE, FL
- Market Status: Active
- CIK Number: 0001402328
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $6.93M
- Round Lot: 100
- Outstanding Shares: 4.56M
- Asset Type: CS
RECENT FILINGS FOR SBFM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | EFFECT | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 424B3 | View |
| 2025-08-12 | RW | View |
| 2025-08-11 | UPLOAD | View |
| 2025-08-11 | CORRESP | View |
| 2025-08-05 | S-1 | View |
| 2025-07-25 | POS AM | View |
| 2025-06-12 | SCHEDULE 13G/A | View |
| 2025-05-23 | SCHEDULE 13G | View |
| 2025-05-19 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-04-11 | SCHEDULE 13G | View |
| 2025-04-03 | 8-K | View |
| 2025-04-03 | 424B5 | View |
| 2025-04-02 | 8-K | View |
| 2025-04-01 | 10-K | View |
| 2025-03-31 | NT 10-K | View |
| 2025-02-14 | SCHEDULE 13G/A | View |
Latest News on SBFM